Critical Path Institute Grants $249,719 to Odylia Therapeutics to Propel Gene Therapy for USH1C-Related Vision Loss
Critical Path Institute Awards $249,719 Grant to Odylia Therapeutics for Groundbreaking Gene Therapy Targeting Usher Syndrome Type 1C Vision Loss ...
